Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: J Investig Med. 2014 Feb;62(2):316–323. doi: 10.231/JIM.0000000000000031

Figure 4.

Figure 4

TSE treatment of LCs prior to use for antigen presentation inhibits LC presentation to CD4+ T cells for IFNγ, IL-4 and IL-17 responses in vitro. BALB/c LCs were exposed in vitro to various dilutions of TSE for 3 hours and then co-cultured with DO11.10 transgenic CD4+ T cells with cOVA323-339. After 48 hours, supernatants were harvested and assessed for content of IFNγ, IL-4 and IL-17. *p<0.001. N = 6/group from 2 experiments.